Patterns and clinical relevance of antibody responses during adalimumab therapy

This item is provided by the institution :
Hellenic Society of Gastroenterology   

Repository :
Annals of Gastroenterology   

see the original item page
in the repository's web site and access all digital files if the item*



Patterns and clinical relevance of antibody responses during adalimumab therapy (EN)

Katsanos, K.H.
Vagias, I.
Tsianos, V.
Tsianos, E.V.

info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion

2010-07-09


All biologic therapies have the potential to induce immunogenicity. Homology reduces antigenicity, but ‘humanization' does not equate with homology and human antibodies may be also immunogenic. Despite of its proved efficacy in Crohn's disease patients, adalimumab carries the potential of molecule-specific toxicities which may be expressed with several types of antibody responses, and which are usually divided as allergic, autoimmunity and immunogenicity phenomena. (EN)


English

Hellenic Society of Gastroenterology (EN)


1792-7463
1108-7471
Annals of Gastroenterology; Volume 23, No 3 (2010); 165 - 171 (EN)




*Institutions are responsible for keeping their URLs functional (digital file, item page in repository site)